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schemes for a specific treatment annd indication across different regions, how-
ever, is not entirely clear. In the United Kingdom, patient access schemes (PAS) are
accepted within submissions to the National Institute for Health and Clinical Ex-
cellence (NICE) in England, and the Scottish Medicines Consortium (SMC) in Scot-
land. We compared guidance published by NICE and the SMC to identify similari-
ties and differences between PAS for the same treatment and indication in these
regions. METHODS: All NICE technology appraisals published in 2010 and 2011
were reviewed. Treatment appraisalswith PASwere identified and the correspond-
ing submissions to the SMC were analysed for the presence and nature of a PAS.
PAS were defined as the manufacturer providing a pre-defined reduction in the
overall cost of treatment through risk-sharing or rebate schemes. RESULTS: In 2010
and 2011, 15 technology appraisals published by NICE included PAS, 13 of which
had equivalent submissions to the SMC. Of these 13 submissions, 7 were recom-
mended by both NICE and the SMC, 1 was recommended only by NICE, and 5 were
rejected by both. For treatments recommended by both NICE and the SMC, only 3
submissions included a comparable PAS, which consisted of a discounted price in
all cases. Of the 4 remaining recommended appraisals, only 2 had a PAS included in
the SMC submission, which was a simple discount in both cases. In the NICE ap-
praisals, however, these submissions included more complicated PAS, such as
treatment cycle rebates and price matching schemes. CONCLUSIONS: There is
some alignment between PAS included in submissions to NICE and the SMC; how-
ever, where there are inconsistencies the SMC appear to accept more simple dis-
counting schemes.
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OBJECTIVES: Older individuals (age  50 years) should receive higher preventive
care to avoid complex health conditions. Rural areas tend to have a higher percent-
age of older individuals, but lower quality of healthcare. This study examines the
geographic variations in the provision of preventive services in the visits made by
older individuals to office-based physicians in US in 2009. METHODS: Data was
derived from National Ambulatory Medical Care Survey (NAMCS) 2009. Visits with
individual age  50 years were analyzed for preventive visits. Preventive visit was
defined as a visit where at-least one preventive service such as health-education/
screening/immunization was provided. The list of preventive services was derived
from the preventive services guidelines recommended by ‘Institute of Clinical Ser-
vices Improvement’ (ICSI), and ‘Healthy People 2020’. Visits outside the Metropol-
itan statistical area were defined as rural visits. Association between geographic
location of physician andpreventive visitswas examined by performing chi-square
analysis using SAS 9.1®. RESULTS: There were 15,847 visits made by older individ-
uals to office based physicians. The proportion of preventive services provided in
rural visits (87.36%) was slightly higher than those provided in urban visits (85.55%)
(p0.0384). However, several key screening services recommended by ICSI were
significantly lower in rural area. These services may require high-technology in-
vestment. These preventive services included; Echocardiography (1.44% vs. 2.98%,
p0.0002), Electrocardiography (3.22% vs. 5.47%, p0.001), Pap-smear (0.55% vs.
1.08%, p0.0358), MRI (1.61% vs. 2.48%, p0.0224), Mammography (1.50% vs. 2.37%,
p0.0189), and Ultra-imaging (2.27% vs. 3.55%, p0.0048). No significant difference
was observed between the geographic location of physician and provision of
health-education or immunizations. CONCLUSIONS: The lower rate of high-tech-
nology screening services in rural area may be due to resource constraints. This
concern needs to be addressed to meet the goals of ‘Healthy People 2020’. Rural
healthcare providers should be well-equipped to increase the screening rates in
older individuals.
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OBJECTIVES: To describe the types of CAM therapies that are frequently offered in
Texas hospices. To assess the factors that influence the likelihood that a hospice
will provide CAM. METHODS: Data was collected via 369 self-administered mail
surveys to hospice directors in the state of Texas. Respondents were identified
through two national and one state hospice directories and were surveyed irre-
spective of their setting or geographical location. A total usable response rate of
35.7% was obtained after an initial and one follow-up mail-out. Binary logistic
regression analysis was used to assess whether the likelihood of offering CAMwas
related to the hospice’s age, geographic location, agency type, profit orientation,
Medicare certification, or number of patients served annually.RESULTS:Amajority
(N 61, 56.4%) of hospices in Texas provide at least one type of CAM to their clients,
with the most frequently offered CAMs being massage (67.7% of respondents),
music (61.3%), and relaxation (56.5%) therapies. The logistic regression analysis
showed that the profit orientation status and the number of patients served by a
hospice were significantly related to the probability that a hospice will offer CAM.
Specifically, the odds of offering CAM in ‘not-for-profit’ hospices were approxi-
mately four times higher than in ‘for-profit’ hospices (OR  3.77, p  0.022, 95%
C.I.  1.2, 11.8). In addition, for every 100 patients served by hospices, the odds of
offering CAM increases by 13% (OR  1.13, p  0.015, 95% C.I.  1.02, 1.25).
CONCLUSIONS: Massage and music therapies are the most commonly offered
CAMs in Texas hospices. CAM provision is related to the number of patients served
and profit orientation status, but is not related to othermeasured characteristics of
hospices.
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OBJECTIVES: To compare trends in emergency room visits versus hospitalizations
due to unintentional poisonings in Kansas City, Missouri, from 2001 to 2008.
METHODS:We conducted a retrospective study using Missouri Hospital Discharge
Data for Kansas City, Missouri. The data included the causes of emergency room
visits and hospitalizations, sex, race, age and zip code. The zip code datawere used
to categorize the patient’s zip code level median family income and to assign the
individual to the appropriate local Health Zone. Unintentional poisonings were
identified by ICD-9 E-code 850.0 to 869.9. Chi-square tests were used to compare
rates of emergency room visits or hospitalizations for each demographic variable.
Multiple logistic regression analyseswere conducted. RESULTS:Unintentional poi-
sonings accounted for 0.4% of the 1,370,453 emergency room visits from all causes
and 0.5% of the 496,502 hospitalizations from all causes. Males had the highest
rates for both emergency room visits and hospitalizations due to unintentional
poisonings. Utilization by age, race, and median family income exhibited opposite
trends for emergency room visits and hospitalizations. Persons utilizing emer-
gency departments were more likely to be younger, white, and reside in higher
median family income zip codes,whereas hospitalized patientsweremore likely to
be older, black, and reside in lower median family income zip codes. These differ-
ences were reflected in the patient’s Health Zone of residence. CONCLUSIONS:
Except sex, trends of emergency room visits and hospitalizations due to uninten-
tional poisonings, were opposite across other demographic variables.
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OBJECTIVES: E-prescribing is the electronic transmittal of a prescription to a phar-
macy from the point of care. Electronic health records (EHR) provide greater func-
tionality beyond e-prescribing and improve the availability of pharmacy benefits
information and patient medication histories. The objective of this study is to
describe the absolute growth in e-prescribing, e-prescribing method changes,
growth in pharmacies accepting e-prescriptions, and discuss the impact of federal
incentives on the e-prescribing adoption rate.METHODS: Pharmacy and prescriber
data used for descriptive analyses are from SureScripts (12/2008 - 9/2011). Standard
descriptive statistics and standard regression analyses were used to analyze the
data. RESULTS: A total of 95% of all chain, franchise, or independently owned
pharmacies in the US route through the SureScripts network. The total number of
health care providers prescribing on the SureScripts network has increased signif-
icantly over time from approximately 75,000 in December 2008 to approximately
420,000 in January 2012 (p0.001). The number of e-prescribers has significantly
increased in trajectory since 2009, which may be due to the federal incentives for
EHRs. Health care providers e-prescribing via EHR systems and via stand-alone
e-prescribing systems also increased, although the trajectory of EHR prescribers is
much higher. Among current prescribers on the SureScripts network, 80% use an
EHR. Currently, prescription refills/renewals comprise only 16% of total transac-
tions. The percentage of total physicians e-prescribing on the SureScripts network
in the US increased during this study period from 2% to 50%. CONCLUSIONS: E-
prescribing is the gateway to the improved patient care that health IT promises.
Prescription refills/renewals show promising benefits, as they are bi-directional
health information exchange. Despite this, physicians have facedmany barriers to
implementation, with cost and workflow change as the primary challenges. Gov-
ernment incentive programs appear to have increased e-prescribing use among
health care providers.
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OBJECTIVES: The growing need for pharmacists to monitor and assess economic
and health outcomes associated with pharmacy products and services provided is
reflected in the most recent US Accreditation Council for Pharmacy Education
(ACPE) guidelines (effective 2007). The last investigation of pharmacoeconomic (PE)
education in US colleges of pharmacy (COP) was conducted in 2007 (before the new
guidelines came into effect). The objective was to conduct a follow-up survey in
2011. METHODS: E-mails requesting syllabi covering pharmacoeconomic topics
were sent to all US Colleges/Schools of pharmacy who had PharmD graduates in
2011 (N  103). A follow-up e-mail was sent to instructors who provided these
syllabi asking for 1) the number of students who completed the course; 2) the
availability of pharmacoeconomic projects; 3) if there were PE rotations available
for PharmD students; and 4) the opinion of the instructor about the sufficiency of
the hours devoted to pharmacoeconomic education. RESULTS: Themajority of the
colleges and schools (78 out of 87 analyzed) covered PE in required courses. The
number of hours dedicated to pharmacoeconomic-related topics varied from 2 to
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60 hours per year. Themedian number of PE hours for required courses was 16 and
the mean number of students enrolled annually was 117. Learning objectives and
covered topics obtained from syllabi and surveys varied among colleges/schools.
CONCLUSIONS: More US Colleges/Schools of Pharmacy required PE education
compared to the 2007 survey, and the number of hours and students in these
courses increased. Although the extent of PE education has increased, a large vari-
ation in the number of teaching hours and list of covered topics among the colleges
and schools demonstrates a lack of uniformity or standardization for this area.
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OBJECTIVES: Optimal allocation of resources in healthcare requires a solid re-
search and educational infrastructure, especially for a developing country like
Egypt. Previous research focusing on pharmacoeconomic education status inter-
nationally did not report any information about the Egyptian case. The purpose of
this study was to assess the existing state of undergraduate and postgraduate
pharmacoeconomics education in the Egyptian schools of pharmacy.METHODS:A
survey methodology was employed in which a previously published survey was
adapted and modified into a 15-item survey to suit our research purpose. The
survey was administered to the head of the department under which offers phar-
macoeconomic related topics or to the dean of the school if not offered. To ensure
a higher response rate, surveyswere administered via e-mail,mail, and face to face
when necessary. RESULTS:We attempted to reach all the schools of pharmacy in
Egypt (n23). We received usable responses from 13 schools of pharmacy (56.5%).
Only 4 schools were offering pharmacoeconomic education at the time of survey
completion with an average of 35 teaching hours per course (median 38.5 hrs).
Average estimated class size was 420 students (range: 280-600). Among the 4
schools offering pharmacoeconomics, only 1 faculty member was trained through
a formal PhD program. Two schools offered pharmacoeconomics education at the
graduate level. Methods of pharmacoeconomic analyses were the most commonly
taught topics. Out of the 13 schools of pharmacy, 9 schools expressed their interest to
teach a course fully dedicated to pharmacoeconomics in the near future (2-4 years).
CONCLUSIONS: Pharmacoeconomic education in Egypt is still in its infancy. Inter-
est was expressed by faculty members in integrating pharmacoeconomics into
pharmacy education. Lack of subject area experts might be a major barrier in such
adoption. There exists a unique opportunity for well-trained individuals to fill this
gap.
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OBJECTIVES: The objective of this research was to validate with provincial drug
plan managers if the guidelines for conducting pharmaceutical budget impact
analyses (BIA) in Canada, published by the PatentedMedicines Prices Review Board
(PMPRB) in 2007, meet their needs. METHODS: A survey entitled Budget Impact
Analysis Requirements by Canadian Provincial Drug Plans was developed and sent by
email to all provincial drug plan managers, at the exception of Quebec. The survey
consisted in 14 questions that take approximately twenty minutes to complete.
RESULTS: The participation rate of the provinces was of 55.6%. In 60% of the par-
ticipating provinces, the person that completed the questionnaire was the drug
plan manager, therefore a reliable source of information. Forty percent of the par-
ticipating provinces prefer that the market size for the BIA to be estimated using a
population data-based model versus a claims data-based model, 40% prefer both
models, and 20% have no specific preference. The guidelines developed by PMPRB
recommend the use of a population data-based model. 100% of the participating
provinces agree that if a comparator will lose its patent over the time horizon, it
should be taken in consideration in the BIA. The guidelines, however, do not pro-
vide any recommendations regarding the inclusion of generic products. Accurate
drug cost reporting is an important component of the BIA. The dollar or percentage
value for wholesaler mark-up, pharmacy mark-up, inventory allowance and dis-
pensing fees provided by 80% participating provinces do not match those recom-
mended by the BIA guidelines. CONCLUSIONS:Overall, the guidelines for conduct-
ing pharmaceutical BIA in Canada, published by PMPRB in 2007, meet the needs of
provincial drug planmanagers. However, they should be updated in order to reflect
the changes that have occurred in the pharmaceutical industry, especially those
around the Canadian price of generics.
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OBJECTIVES: The main role of AOTM is to prepare recommendations on financing
all medical technologies from public funds for the Minister of Health. For all new
health technologies entering market full pharmacoeconomic evaluations are re-
quired before reimbursement decisions are taken. The aim of the present analysis
was to identify what was the impact of low efficacy on AOTM negative recommen-
dations issued for innovative drugs. METHODS: All recommendations issued by
AOTM in 2011 were reviewed and analyzed.We distinguished those regarding only
innovative drugs (other recommendations were excluded) and identified the rea-
son for negative statement. RESULTS: In 2011 AOTM issued 111 recommendations
for medical technologies and . services. 85 (76%) were connected with new medi-
cines (innovative drugs). The full positive decisions were given for 51 drugs (60%).
For 16 of 85 (19%) drugs AOTM issued conditional recommendations (with restric-
tion related with reducing the cost- effectiveness outcomes). Negative recommen-
dations were given for reimbursement to 18 of 85 (21%) of innovative drug submis-
sions. In one case budget impact and the corresponding high prices were
emphasized as a main reason of negative recommendations. Also only in one case
the reason was connected with drug safety issues, while in 16 cases with insuffi-
cient evidence of efficacy CONCLUSIONS: Low efficacy of appraised innovative
drugs was a key factor of negative recommendations published by AOTM in 2011.
Neither cost-effectiveness nor costs, safety and budget impact were significant
arguments in negative recommendations of AOTM.
PHP75
A WEB APPLICATION TOOL FOR ENHANCED MEDICATION UTILIZATION
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Burk M, Moore V, Cunningham FE, Glassman P, Good CB
VA Center for Medication Safety, Hines, IL, USA
OBJECTIVES: The VA Center for Medication Safety has developed a data-extract
driven, web-based, user-interface application for a medication utilization evalua-
tion tracker (MUET). MUET identifies at-risk patients as well as records, stores, and
tracks clinical interventions in a centralized interactive VA database accessible to
all 152 VA Medical Centers (VAMCs). The objective of this study is to describe the
impact of a MUET tool designed to address the safety and monitoring needs of
at-risk patients on erythropoiesis stimulating agents (ESAs) and to enable inter-
ventions to be tracked in a centralized database. METHODS: Data are extracted
from the VA PBM prescription and laboratory databases each month, and poten-
tially at-risk patients on ESA therapy are loaded into the MUET tool. Four trigger
groups indicating quality of care issues are identified: No Hgb, Hgb  12 and  13
g/dL, Hgb  13 g/dL, and Hgb  9 g/dL with no recent ferritin assessment. Upon
log-in toMUET, clinicians are prompted to address the safety needs of each patient
by selecting from a list of interventions that are recorded and tracked over time.
RESULTS: Approximately 2.5 years after ESA MUET initiation, chi-square tests
showed decreases in patients without Hgb labs (11.4% to 3.0%, p0.0001); in pa-
tients with Hgb  12 g/dL and  13 g/dL (12.7% - 7.3%, p0.0001); and in patients
with Hgb  13 g/dL (5.7% - 3.0%, p0.0001). A non-significant decrease was ob-
served in patients with Hgb 9 g/dL andwithout a ferritin assessment (3.1% - 2.8%,
p0.3960). CONCLUSIONS: The ESA MUET is a real-time web application tool ac-
cessible by all medical centers within the VA health care network to identify and
intervene on patients at potential risk. Data trends demonstrate significant im-
provements in 3 out of 4 ESA risk groups.
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OBJECTIVES: As technological advances are becoming common in hospitals, its
impact on work efficiency also needs to be evaluated. The objective of this study
was to evaluate the long term effect of a bedside bar-coded medication adminis-
tration system and a medication dispensing system on the time taken for the
medication administration process. METHODS: A prospective cohort study was
conducted to compare medication administration time before and after the inter-
vention in an intensive care unit in a large tertiary hospital using a pre-validated
time and motion observation instrument. Bedside bar-coded medication adminis-
tration system was implemented in July 2008 and the medication dispensing sys-
tem was implemented on November 2009. Pre-intervention data were collected in
April-May 2008 and post-intervention data were collected in June-July 2010. Mean
duration of time dedicated to medication administration activity was compared.
Multivariate analysis of covariance (MANCOVA) was conducted to assess the effect
of the intervention by controlling factors such as patients’ age, gender, body-
weight and length of ICU stay, number of drugs administered, and number of
nurses involved. RESULTS: A total of 101 pre-intervention and 109 post-interven-
tion medication administrations were recorded. Mean ( SD) overall medication
administration time was increased from 313.3 (224.3) seconds during pre-inter-
vention period to 613.7 (348.7) seconds during the post-intervention period.
Nurses spent significantly (p0.05) more time on direct patient care activity (pre:
47.460.6 seconds, post: 89.178.5 seconds) and less time on indirect patient care
activity (pre: 13.0 25.8 seconds, post: 6.1 13.8 seconds, p0.05) during post-
intervention period. CONCLUSIONS: Health technology intervention improved
time spent on direct patient care activity and reduced time spent on indirect pa-
tient care activity after implementation of bedside bar-code technology and amed-
ication dispensing system.
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PERFORMANCE OBSTACLES AND EASE OF WORK
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OBJECTIVES: To evaluate perception of nurses regarding performance obstacles
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